Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Amgen stock rebounds after addressing MariTide concerns

November 14, 2024
Amgen Inc. (NASDAQ: AMGN), a leading biotechnology company, saw a surge in its stock price as concerns regarding the safety of its obesity drug, MariTide, were addressed. The company denied any bone safety concerns linked to the drug and reassured investors that it is committed to the highest safety standards. This news comes as a relief to shareholders who were worried about the potential impact on the company's financial performance. Amgen's stock gained momentum as investors regained confidence in the company's ability to navigate through challenges and deliver positive results. To make informed investment decisions and take advantage of the stock's growth, professionals at Stocks Prognosis recommend considering buying Amgen's shares.

Find out how the AMGEN INC. rate is expected to change

Get Forecast for AMGN

Investor opinions & comments:

This news is reassuring, I feel more confident about Amgen's future now
— from DavidWilson at 11-17-2024 16:12
I'm interested to see how this positive news will impact Amgen's financial performance
— from WyattRiley at 11-17-2024 06:30
I'm glad the safety concerns have been addressed. I might consider buying some Amgen shares now
— from CharlesScott at 11-16-2024 23:52
I'm skeptical about the company's reassurances. It's always better to be cautious when it comes to pharmaceuticals
— from HannahCarter at 11-16-2024 18:45
I'm still not completely convinced about the safety of MariTide. I need more evidence before considering investing in Amgen
— from IsaacPerry at 11-15-2024 13:22
If you want to leave a comment, then you need Login or Register





Other news for AMGN

AMGNApril 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025  ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....

AMGNMarch 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy  ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....

AMGNMarch 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market  ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....

AMGNMarch 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance  ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....

AMGNMarch 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy  ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....



Related news

REGNJanuary 4, 2025Regeneron Pharmaceuticals Inc.: A Strong Investment Opportunity for Shareholders  ~1 min.

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) has proven to be a successful investment option for shareholders, with a decent 89% return over the last five years....

VRTXJanuary 6, 2025Investors Should Consider Buying Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Now  ~2 min.

Vertex Pharmaceuticals Incorporated is a leading biotechnology company specializing in the discovery, development, and commercialization of innovative medicines for serious diseases....

REGNJanuary 12, 2025Regeneron Pharmaceuticals Faces Shareholder Class Action Lawsuit  ~1 min.

Regeneron Pharmaceuticals, Inc., a leading biotechnology company, is currently facing a shareholder class action lawsuit....

BIIBJanuary 24, 2025Nisa Investment Advisors LLC Purchases 149461 Shares of Biogen Inc. NASDAQ:BIIB  ~1 min.

Nisa Investment Advisors LLC, a renowned investment firm, has recently made a significant investment in Biogen Inc., acquiring 149,461 shares of the company's stock....

AMGNDecember 16, 2024Amgen Inc. Announces Q1 2025 Dividend: 2.38 Per Share Payout for Shareholders  ~1 min.

Amgen Inc., a leading biotechnology company, recently announced its first-quarter dividend for 2025. Shareholders can expect a payout of $2....